NCT04045704

Brief Summary

The degree at which cataract surgery improves visual function in patients with advanced age-related macular degeneration (Advanced AMD) has been an on-going topic of discussion. Our objective in this study is to determine if patients with Advanced AMD and concurrent cataracts will experience greater improvement in their quality of life from having cataract surgery on one or both eyes. The findings from this project will provide evidence for clinical decision making on whether performing bilateral cataract surgery on Advanced AMD patients is cost-effective and worth the second surgical intervention.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2019

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 5, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

October 4, 2021

Status Verified

September 1, 2021

Enrollment Period

2 months

First QC Date

July 17, 2019

Last Update Submit

September 27, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Life style Questionnaire to determine change in visual function.

    Our primary outcome will be a life style questionnaire (qualitative) to determine the change in visual function from baseline to after surgery. This questionnaire includes 25 close-ended questions that are graded on a 5 point grading scale from 1 (great difficulty due to vision) and 5 (no problem due to vision). The questions can also be graded as not applicable to an individuals life, or 0 being something there are no longer possible to do, due to vision. The 25 close-ended questions are divided into 4 sub-scales: 1. Distance Vision, Mobility, and Lighting (Q: 1-12) 2. Adjustment (Q:13-16) 3. Reading and Fine Work (Q: 17-21) 4. Activities of Daily Living (Q: 22-25) A total score can range from a 125 indicating best visual function to 0 indicating complete loss of visual function.

    Through study completion, an average of 1 year

Secondary Outcomes (2)

  • Snellens Chart to determine change in visual acuity

    Through study completion, an average of 1 year

  • Auto Refractive to determine change in visual acuity

    Through study completion, an average of 1 year

Interventions

Patients with bilateral Advanced Age-related macular degeneration and concurrent cataracts will be receiving bilateral cataract surgery

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients above the age of fifty with both Advanced AMD and Cataracts bilaterally from the Okanagan Valley will be selected for this study.
  • Patients who chose to have bilateral cataract surgery, were able to understand the research parameters, and had no other severe eye disease that may distort the studies results.
  • Patients will be selected for the study according to the National Eye Institute definition of Advanced AMD.
  • "Advanced AMD (AREDS category 4) is characterized by one or more of the following (in the absence of other causes) in one eye:
  • Geographic atrophy of the RPE involving the foveal center.
  • Neovascular maculopathy that includes the following:
  • Choroidal neovascularization (CNV) defined as pathologic angiogenesis originating from the choroidal vasculature that extends through a defect in Bruch's membrane
  • Serous and/or hemorrhagic detachment of the neurosensory retina or RPE
  • Retinal hard exudates (a secondary phenomenon resulting from chronic intravascular leakage)
  • Subretinal and sub-RPE fibrovascular proliferation
  • Disciform scar (subretinal fibrosis)"

You may not qualify if:

  • Severe intraoperative or postoperative complications such as retinal detachments, and capsule ruptures
  • Inability to complete the required testing (auto-refractive and visual acuity)
  • Inability to attend appointments
  • Inability to complete the questionnaire with Co-I assistance
  • Severe eye disease that may distort the studies results such as but not limited to Epithelial Basement Membrane Dystrophy (EBMD) and retinal detachments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cataract

Interventions

Cataract Extraction

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

July 17, 2019

First Posted

August 5, 2019

Study Start

October 1, 2019

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

October 4, 2021

Record last verified: 2021-09